LCM
Lazari Capital Management Portfolio holdings
AUM
$266M
This Quarter Return
-3.25%
1 Year Return
+23.56%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$245M
AUM Growth
+$245M
(-2.5%)
Cap. Flow
+$6.34M
Cap. Flow
% of AUM
2.59%
Top 10 Holdings %
Top 10 Hldgs %
54.82%
Holding
163
New
10
Increased
52
Reduced
70
Closed
8
Top Buys
| 1 |
Vanguard High Dividend Yield ETF
VYM
|
$1.33M |
| 2 |
Vanguard Mega Cap Growth ETF
MGK
|
$1.12M |
| 3 |
Pfizer
PFE
|
$764K |
| 4 |
Costco
COST
|
$620K |
| 5 |
Microsoft
MSFT
|
$599K |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$454K |
| 2 |
Eli Lilly
LLY
|
$390K |
| 3 |
Trade Desk
TTD
|
$384K |
| 4 |
Gilead Sciences
GILD
|
$320K |
| 5 |
Airbnb
ABNB
|
$283K |
Sector Composition
| 1 | Technology | 33.26% |
| 2 | Communication Services | 17.89% |
| 3 | Consumer Discretionary | 10.72% |
| 4 | Financials | 7.11% |
| 5 | Energy | 5.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vivani Medical
VANI
$68.7M
| $10.5K | ﹤0.01% |
10,000
| – | – |
|
152
Lineage Cell Therapeutics
LCTX
$281M
| $4.89K | ﹤0.01% |
10,817
-147
| -1% | -$66 |
|
153
Stem
STEM
$121M
| $4.41K | ﹤0.01% |
12,574
| – | – |
|
154
X4 Pharmaceuticals
XFOR
$70M
| $2.36K | ﹤0.01% |
10,000
| – | – |
|
|
ZOM
155
DELISTED
Zomedica Corp.
ZOM
| – | – |
-10,000
| Closed | -$1.2K |
|
|
156
Trade Desk
TTD
$26.3B
| – | – |
-3,267
| Closed | -$384K |
|
157
KeyCorp
KEY
$20.8B
| – | – |
-10,498
| Closed | -$180K |
|
158
iShares Russell 1000 Growth ETF
IWF
$117B
| – | – |
-565
| Closed | -$227K |
|
|
159
Airbnb
ABNB
$76.5B
| – | – |
-2,150
| Closed | -$283K |
|
160
Applied Materials
AMAT
$124B
| – | – |
-1,327
| Closed | -$216K |
|
161
Comcast
CMCSA
$125B
| – | – |
-5,461
| Closed | -$205K |
|
|
162
Gilead Sciences
GILD
$140B
| – | – |
-3,463
| Closed | -$320K |
|